Renaud Savary

Renaud Savary is Senior Investment Analyst, Pharmaceutical Sector, at Avem Capital.

Articles by Renaud Savary

Latest Updated Articles

Trending on PharmExec

Novartis, Bristol Myers Pause Autoimmune CAR-T Trials Over Safety Concerns: Report

Your Questions Answered: The Biggest Pharma and Biotech Stories This Week

What's Next for Compounded Peptides: Q&A with Nate Hill

Pharmaceutical Executive Daily: FDA Approves Zanvastro

Roundup: Alteogen Enters Option & License Agreement with Novartis, NewBiologix & Synastra Form BioTech Partnership, RedHill Acquires Commercialization Rights to Rebyota & Clenpiq